Pharma Force
0859.585.888 · rovalta.com · 24/09/2026
Pharma Force
Overview
What does Pharma Force do?
Pharma Force is a Public limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Gent. It employs on average 105,4 ETP workers (FTE).
9051 Gent · FlandreSee on map
Joint committees (1)
- 313
Trend over 13 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||
| Revenue | 23,1 M € | -5.2% | 24,4 M € | +2.4% | 23,8 M € | -7.1% | 25,6 M € | -1.5% | 26 M € | +8.1% | 24,1 M € | +8.8% | 22,1 M € | -3.3% | 22,9 M € | +70.9% | 13,4 M € | -51.8% | 27,8 M € | -11.3% | 31,3 M € | -19.4% | 38,9 M € | +3.4% | 37,6 M € |
| EBITDA | 2,7 M € | -13.0% | 3,1 M € | -13.1% | 3,5 M € | -29.4% | 5 M € | -8.9% | 5,5 M € | +52.6% | 3,6 M € | +262% | 991,5 k € | +211% | -890,8 k € | +64.4% | -2,5 M € | +0.6% | -2,5 M € | -8.1% | -2,3 M € | -1265% | -170,3 k € | -114% | 1,2 M € |
| Operating result | 2,1 M € | -17.7% | 2,5 M € | -18.0% | 3,1 M € | -33.1% | 4,6 M € | -9.7% | 5,1 M € | +57.5% | 3,2 M € | +671% | 416,4 k € | +124% | -1,7 M € | +44.3% | -3,1 M € | -0.9% | -3 M € | +5.9% | -3,2 M € | -4699% | 70 k € | -69.3% | 228,2 k € |
| Net result | 1,9 M € | -12.9% | 2,2 M € | -22.0% | 2,8 M € | -33.2% | 4,3 M € | -3.9% | 4,4 M € | +43.1% | 3,1 M € | +1478% | 196,3 k € | +110% | -2 M € | +44.0% | -3,7 M € | -4.4% | -3,5 M € | -118% | -1,6 M € | -800% | -178,8 k € | -577% | 37,5 k € |
| Balance sheet | |||||||||||||||||||||||||
| Equity | 11,2 M € | +20.7% | 9,3 M € | +31.2% | 7,1 M € | +66.8% | 4,3 M € | +235100% | -1,8 k € | +100.0% | -4,4 M € | +41.1% | -7,5 M € | +2.5% | -7,7 M € | -1052% | -670,9 k € | +77.7% | -3 M € | -716% | 489,1 k € | +399% | 98 k € | -64.6% | 276,8 k € |
| Total assets | 15,7 M € | +9.9% | 14,3 M € | -6.3% | 15,3 M € | +7.9% | 14,2 M € | -7.5% | 15,3 M € | +10.6% | 13,8 M € | +56.8% | 8,8 M € | -7.9% | 9,6 M € | -54.1% | 20,9 M € | +33.8% | 15,6 M € | +7.8% | 14,5 M € | -25.3% | 19,4 M € | +13.7% | 17,1 M € |
| Cash | 140,9 k € | -2.1% | 143,9 k € | -46.1% | 266,7 k € | -23.6% | 349,1 k € | +78.2% | 195,9 k € | +124% | 87,3 k € | +116% | 40,4 k € | -10.5% | 45,2 k € | -97.5% | 1,8 M € | +39.5% | 1,3 M € | -22.7% | 1,7 M € | +81.8% | 912,1 k € | +582% | 133,7 k € |
| Debts | 4,5 M € | -10.2% | 5 M € | -38.8% | 8,2 M € | -17.4% | 9,9 M € | -35.3% | 15,3 M € | -16.1% | 18,3 M € | +11.7% | 16,3 M € | -4.6% | 17,1 M € | -17.8% | 20,9 M € | +14.1% | 18,3 M € | +34.8% | 13,6 M € | -29.8% | 19,3 M € | +15.1% | 16,8 M € |
| Other | |||||||||||||||||||||||||
| Workforce | 105,4 ETP | -0.7% | 106,1 ETP | -0.4% | 106,5 ETP | -5.8% | 113,0 ETP | +5.5% | 107,1 ETP | +8.2% | 99,0 ETP | +20.3% | 82,3 ETP | +6.6% | 77,2 ETP | +9.2% | 70,7 ETP | +1.9% | 69,4 ETP | +32.7% | 52,3 ETP | +14.4% | 45,7 ETP | -0.4% | 45,9 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2024 · 1 active · 35 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2025 | 31/07/2024 | 11/07/2023 | 24/06/2022 | 27/08/2021 | 27/08/2021 |
| General meeting | 14/06/2025 | 28/06/2024 | 30/06/2023 | 20/05/2022 | 25/08/2021 | 25/08/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
22 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2024 | 14/06/2025 | 23/06/2025 | Dutch | |
| Full model | 31/12/2023 | 28/06/2024 | 31/07/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 11/07/2023 | Dutch | |
| Full model | 31/12/2021 | 20/05/2022 | 24/06/2022 | Dutch | |
| Full modelCorrection | 31/12/2020 | 25/08/2021 | 27/08/2021 | Dutch | |
| Full model | 31/12/2020 | 10/06/2021 | 24/06/2021 | Dutch | |
| Full modelCorrection | 31/12/2019 | 25/08/2021 | 27/08/2021 | Dutch | |
| Full model | 31/12/2019 | 07/07/2020 | 20/07/2020 | Dutch | |
| Full model | 31/12/2018 | 26/06/2019 | 11/07/2019 | Dutch | |
| Full model | 31/12/2017 | 29/06/2018 | 20/07/2018 | Dutch | |
| Full model | 31/12/2016 | 05/10/2017 | 09/10/2017 | Dutch | |
| Full model | 31/12/2015 | 30/06/2016 | 04/07/2016 | Dutch | |
| Full model | 31/12/2014 | 31/08/2015 | 14/09/2015 | Dutch | |
| Full model | 31/12/2013 | 30/06/2014 | 07/08/2014 | Dutch | |
| Full model | 31/12/2012 | 25/10/2013 | 13/12/2013 | Dutch | |
| Full model | 31/12/2011 | 26/09/2012 | 27/09/2012 | Dutch | |
| Full model | 30/06/2010 | 10/06/2011 | 04/10/2011 | Dutch | |
| Full model | 31/12/2009 | 14/07/2010 | 29/10/2010 | Dutch | |
| Full model | 31/12/2008 | 30/06/2009 | 10/08/2009 | Dutch | |
| Full model | 31/12/2007 | 03/09/2008 | 06/10/2008 | Dutch | |
| Full model | 31/12/2006 | 31/08/2007 | 28/09/2007 | Dutch | |
| Full modelCorrection | 31/12/2005 | 08/11/2006 | 30/03/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 1 active · 35 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates14/04/2023ONTSLAGEN - BENOEMINGEN
- Mandates20/01/2020KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates13/12/2018ONTSLAGEN - BENOEMINGEN
- Mandates18/09/2018ONTSLAGEN - BENOEMINGEN
- Mandates04/04/2018ONTSLAGEN - BENOEMINGEN
- Mandates08/02/2018ONTSLAGEN - BENOEMINGEN
- Mandates19/01/2018ONTSLAGEN - BENOEMINGEN
- Mandates30/08/2017ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 20241,9 M €↓
- 2023Annual accounts 20232,2 M €↓
- 2022Annual accounts 20222,8 M €↓
- 2021Annual accounts 20214,3 M €↓
- 2020Annual accounts 20204,4 M €↑
- 2019Annual accounts 20193,1 M €↑
- 2018Annual accounts 2018196,3 k €↑
- 2017Annual accounts 2017-2 M €↑
- 2017Name changePharma Force
- 2010Annual accounts 2010-3,7 M €↓
- 2009Annual accounts 2009-3,5 M €↓
- 2008Annual accounts 2008-1,6 M €↓
- 2007Annual accounts 2007-178,8 k €↓
- 2006Annual accounts 200637,5 k €
- 2006Name changePATRONA PHARMA GROUP
- 08/07/2003IncorporationPublic limited company